Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Neurological and cognitive problems news


From To
HIV May Persist in the Brain Despite Antiretroviral Treatment

After almost a decade on antiretroviral therapy, half of study participants still had HIV in immune cells in their brain and spinal fluid.

17 July 2019
Teens with HIV have similar cognitive outcomes to HIV-negative peers

Teens who were perinatally infected with HIV and received treatment have similar cognitive outcomes compared with their HIV-negative peers, according to research published in Clinical Infectious Diseases. However, researchers observed that HIV-positive adolescents had decreased executive functioning over time, suggestive of earlier brain damage.

27 May 2019
Young people born with HIV more likely to have “mild” verbal memory test deficits if they have ever had an AIDS-defining condition

A study presented at this year’s Conference on Retroviruses and Opportunistic Infections (CROI 2019) in Seattle found that young people born with HIV performed worse when

18 April 2019
Gus Cairns
Effect of Depression, Lifestyle on Cognitive Function in PLWHIV

Compared with patients without HIV, the poorer cognitive performances of PLWHIV were partly mediated by a higher prevalence of depressive symptoms.

26 March 2019
Infectious Disease Advisor
Specialist memory clinic in Brighton shows that HIV-associated cognitive disorder is being over-diagnosed

Cognitive impairment in people with HIV has multiple causes and HIV-associated neurocognitive disorder is being over-diagnosed, clinicians from Brighton report in Brain Sciences. Assessment of patients attending a specialist

27 February 2019
Michael Carter
Diagnosis and Treatment of Cognitive Impairment in HIV Patients

A UK-based clinic report the results of its memory assessment service.

19 February 2019
American Journal of Managed Care
Efavirenz and psychological performance in children living with HIV

Efavirenz remains a clinically effective and relevant antiretroviral drug for people living with HIV – but adverse side effects need to be screened for and monitored in children.

15 February 2019
Unpacking pain: what causes it and why it’s hard to measure

Pain is difficult to measure. Unlike using a thermometer to measure body temperature, a blood test to measure blood glucose, or a magnetic resonance imaging (MRI) scan to detect a tumour, there are no instruments or tests that objectively measure pain. To understand why, one needs to understand what pain is.

17 December 2018
The Conversation
Stigma impairs cognition in men living with HIV

A new study has drawn a direct link between the amount of stigma men with HIV report experiencing and their scores on cognitive tests, measuring abilities such as memory and attention.

29 November 2018
Eurekalert Inf Dis
ART Reduces Neurocognitive Impairment in Patients Living With HIV

Initiating antiretroviral therapy (ART) may reduce the risk for neurocognitive impairment in patients living with HIV, according to study results published in Clinical Infectious Diseases.

12 October 2018
Infectious Disease Advisor
← First12345...18Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.